Members of this family are frequently de-regulated in cancer, including ORP5 in pancreatic cancer and lung cancer [33,34], ORP7 in breast cancer [35], and OSBP2 in cholangiocarcinoma [36]. This evidence concerns the gene OSBP2 and pancreatic neoplasm.